ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Granules Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Granules Pharmaceuticals, INC. (Granules Pharmaceuticals 401(k) Plan & Trust · EIN 47-2137127 · PN 001): $8.46M net assets, 312 active participants, and $19.31 per $10,000 (19.31 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorGranules Pharmaceuticals, INC.
Filing IdentifierGranules Pharmaceuticals 401(k) Plan & Trust · EIN 47-2137127 · PN 001
Plan Category & State401(k) Defined Contribution (VA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$8.46M
Active Participants312
Direct Admin Fee Rate$19.31 per $10,000 (19.31 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderLpl Financial Rpcp
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($128,872, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI